KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Other financing activities (2021 - 2024)

Ginkgo Bioworks Holdings (DNA) has disclosed Other financing activities for 2 consecutive years, with $604000.0 as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Other financing activities changed N/A year-over-year to $604000.0, compared with a TTM value of $34.7 million through Dec 2023, changed N/A, and an annual FY2025 reading of $1.3 million, up 33400.0% over the prior year.
  • Other financing activities was $604000.0 for Q4 2023 at Ginkgo Bioworks Holdings, up from -$1000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $34.1 million in Q3 2021 and bottomed at -$67000.0 in Q4 2021.